The principal barriers to CRISPR-Cas9 genome editing of bacteria are discussed, the current strategies for addressing these barriers are evaluated, and emerging approaches aimed at improving the efficiency, reliability and precision in bacterial genome engineering are highlighted.
Clustered regularly interspaced short palindromic repeats (CRISPR) and associated (Cas) systems have revolutionized the field of genome engineering by providing versatile, efficient, and programmable tools for precise genetic manipulation. Originally identified as an adaptive immune mechanism in prokaryotes, CRISPR/Cas...
E. Cakiroglu, Serif Senturk· Methods in molecular biology· 0 citations
Where genetic accessibility can be established, the integration of CRISPR technology with synthetic biology may enable more precise gene regulation and could support the development of next-generation engineered Bifidobacterium-based platforms.
Today, the use of CRISPR-Cas systems for genome editing and modification in diverse microbial species is widespread. Originally identified as bacterial defense mechanisms against viral invaders, CRISPR-Cas systems are present across a broad spectrum of microbial taxa, including bacteria and archaea. These systems are c...
B. Nowruzi, Hassan Beiranvand, Armita Biglari· Medical Sciences Journal of...· 0 citations
Recent advances in CRISPR-Cas9–mediated genome editing are highlighted, emphasizing breakthroughs in primary cell editing and the development of translational models for genetic diseases and diabetes mellitus.
Md Nur Islam, Md. Mahmudul Islam, Han Feng et al.· Molecular Biology Reports· 0 citations
Clinical applicability is limited by issues such off-target effects, PAM sequence restrictions, DNA damage-induced toxicity, and immunological responses to Cas proteins, despite its wide therapeutic potential, but improvements in delivery methods and high-fidelity Cas9 variations are being addressed.
Sanjeyan N., G. G., H. S et al.· International Journal of Bas...· 0 citations